Profile: Female Health Co (FHCO.OQ)
8.87USD
1 Aug 2013
$-0.31 (-3.38%)
$9.18
$9.15
$9.15
$8.78
31,803
38,419
$10.21
$5.60
The Female Health Company (FHC), incorporated in 1971, manufactures, markets and sells the FC2 female condom. FC2 is approved by the United States Food and Drug Administration (FDA) that provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS). Prior to October 2009, the Company completed the transition from its first generation product, FC1, to its second generation product, FC2, and production of FC1 ceased. Although FC1 production has ceased, the Company retains its ownership of certain worldwide rights to FC1, as well as various patents, regulatory approvals and other intellectual property related to FC1. From introduction its in March 2007, through September 30, 2011, approximately 109 million FC2 female condoms have been distributed in 120 countries and it is sold directly to consumers in 14 countries.
The FC2, the Company’s second generation female condom, has basically the same physical design, specifications, safety and efficacy profile as FC1. It is manufactured from a nitrile polymer formulation that is exclusive to the Company.
The Company’s customers are primarily global agencies, such as United Nations Population Fund (UNFPA) and the United States Agency for International Development (USAID), through its facilitator, John Snow, Inc. The Company's other customers include non-government organizations, ministries of health and other governmental agencies, which purchase and distribute the FC2 female condom for use in HIV/AIDS prevention programs. FC2 consists of a soft, loose fitting sheath and two rings: an external ring of rolled nitrile and a loose internal ring, made of flexible polyurethane, FC2’s soft sheath lines the vagina, preventing skin-to-skin contact during intercourse. Its external ring remains outside the vagina, partially covering the external genitalia. The internal ring is used for insertion and helps keep the device in place during use. The Company has distribution agreements and other arrangements with commercial partners, which market directly to consumers in 14 countries, including the United States, Brazil, Spain, France, and India. These agreements are generally exclusive for a single country. Under these agreements, the Company sells the FC2 female condom to the distributor partners, who market and distribute the product to consumers in the established territory.
Company Address
Female Health Co
Suite 2225, 515 N. State Street
CHICAGO IL 60654
P: +1312.5959123
F: +1312.5959122
Company Web Links
| Name | Compensation |
|---|---|
Overton Parrish |
1,094,440 |
Michele Greco |
-- |
Michael Pope |
577,711 |
Janet Lee |
-- |
Mary Leeper |
255,167 |

